The data shown was taken in each case from the latest announcement communicated by the shareholder.
Ordinary Shares:
Release according to § 33 Abs. 1 WpHG
| 96.20% | Grifols S.A.*/** |
| 0.13% | Polygon Global Partners LLP |
| 0.07% | UBS Group AG |
* On 2 May 2022, Grifols, S.A. published in accordance with sec. 23 para. 2 sentence 1 WpÜG, that Grifols, S.A. acquired further 0.94 % of the voting rights in Biotest AG. Therefore, Grifols, S.A. holds 97.14 % of the voting right in Biotest AG.
** On 6 June 2025, Grifols Biotest Holding GmbH announced in its final announcement that a further 2.1072% of Biotest ordinary shares had been accepted. Grifols S.A. now holds a total of 99.25% of the voting rights in Biotest AG.
Preference Shares:
As of 31 December 2025:
| 61.56% | Grifols S.A.*** |
| 28.44% | Free float |
*** As of 31 December 2025, Grifols S.A. (amongst other via Grifols Biotest Holding GmbH) held 61.56% of the preference shares in Biotest AG. (Source: Grifols S.A.)